ARX nets 3.6x on sale of DCB

Samantha Birchall 26 March 2020

Healthcare

ARX's exit has generated a 3.6x return multiple and an IRR exceeding 25%.

Next article »

« Previous article

Related Articles

Hypax carves out Precision Colour Printing from Claverley Group

03/05/24

Bluewater sells Rovop to US marine transportation business

03/05/24

Nordian merges spun-off food specialists to form Benelux-focused food group

03/05/24

CapMan Growth’s third fund hits €130m hard-cap

03/05/24

PAI Partners carves out Fresenius Vamed’s European rehabilitation business

03/05/24

Alto Partners and Arca Fondi boost PE portfolio with acquisition of Eurosirel

03/05/24

Search